TN2013000026A1 - Use of sigma ligands in opioid - induced hyperalgesia - Google Patents

Use of sigma ligands in opioid - induced hyperalgesia

Info

Publication number
TN2013000026A1
TN2013000026A1 TNP2013000026A TN2013000026A TN2013000026A1 TN 2013000026 A1 TN2013000026 A1 TN 2013000026A1 TN P2013000026 A TNP2013000026 A TN P2013000026A TN 2013000026 A TN2013000026 A TN 2013000026A TN 2013000026 A1 TN2013000026 A1 TN 2013000026A1
Authority
TN
Tunisia
Prior art keywords
opioid
induced hyperalgesia
sigma ligands
sigma
hyperalgesia
Prior art date
Application number
TNP2013000026A
Other languages
French (fr)
Inventor
Hernandez Jose Miguel Vela
Daniel Zamanillo-Castanedo
Riera De Conias Margarita Puig
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/063286 external-priority patent/WO2012016980A2/en
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of TN2013000026A1 publication Critical patent/TN2013000026A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to the use of a sigma ligand, particularly a sigma ligand of formula (I) to prevent and/or treat opioid-induced hyperalgesia (OIH) associated to opioid therapy.
TNP2013000026A 2011-08-02 2013-01-28 Use of sigma ligands in opioid - induced hyperalgesia TN2013000026A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/063286 WO2012016980A2 (en) 2010-08-03 2011-08-02 Use of sigma ligands in opioid-induced hyperalgesia

Publications (1)

Publication Number Publication Date
TN2013000026A1 true TN2013000026A1 (en) 2014-06-25

Family

ID=54360737

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000026A TN2013000026A1 (en) 2011-08-02 2013-01-28 Use of sigma ligands in opioid - induced hyperalgesia

Country Status (1)

Country Link
TN (1) TN2013000026A1 (en)

Similar Documents

Publication Publication Date Title
MX350828B (en) Use of sigma ligands in opioid-induced hyperalgesia.
TN2013000227A1 (en) Use of sigma ligands in bone cancer pain
TN2013000508A1 (en) Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer
SG10201903119QA (en) Polypeptide vaccine
MX356525B (en) Aav -vectors for use in gene therapy of choroideremia.
NZ702244A (en) Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
EP2569434A4 (en) Compositions and methods for treating leukemia
MX2013010969A (en) Cyclopropylamines as lsd1 inhibitors.
TN2013000460A1 (en) Use of sigma ligands in diabetes type-2 associated pain
MX2014012477A (en) Pyrrolopyrazone inhibitors of tankyrase.
MX2014014832A (en) Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase.
MX2021005172A (en) Nhe3-binding compounds and methods for inhibiting phosphate transport.
HK1171945A1 (en) Sigma ligands for the prevention or treatment of pain induced by chemotherapy
HK1183447A1 (en) Sigma ligands for the prevention and or treatment of emesis induced by chemotherapy or radiotherapy
PH12015501038A1 (en) Inhibitors of iap
TN2013000283A1 (en) Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents
IL227097B (en) Combination comprising a proteasome inhibiting compound and an akt inhibitor, kit comprising same and use thereof for treating cancer
MX2013010050A (en) Proteasome inhibitor delanzomib for use in the treatment of lupus.
JO3145B1 (en) Compounds useful for inhibiting chk1
IN2014DN02482A (en)
MX2013010947A (en) Gallium complexes, pharmaceutical compositions and methods of use.
MX362111B (en) A method of improving liver function.
MX2014006255A (en) Metalloporphyrin neurological treatments.
TN2013000026A1 (en) Use of sigma ligands in opioid - induced hyperalgesia
WO2012158776A3 (en) Combination therapy for treatment of cancer